Directors buy following Proximagen deal
Three directors in AIM-quoted biotech sector consolidator Proximagen have added to their holdings following the company's deal with BrainCells Inc for its sabcomeline programme. The Proximagen share price was flat yesterday but the news of the share buying sparked it into life and it ended up 16.5p
Read more